LIVE GMP
🔥 Kwick Forensic: Listed @190 (+86.67%)
Lumino Industries: Listed @110 (+46.34%)
🌟 Rays of Belief: GMP +₹13 (Closes Today)
💍 Deepa Jewellers: GMP +₹18 (Closes Today)
🚀 Kanohar Electricals: GMP +₹140 (22.15%)
📈 Qualiance Intl: GMP +₹55 (43.31%)
🔥 Kwick Forensic: Listed @190 (+86.67%)
Lumino Industries: Listed @110 (+46.34%)
🌟 Rays of Belief: GMP +₹13 (Closes Today)
💍 Deepa Jewellers: GMP +₹18 (Closes Today)
🚀 Kanohar Electricals: GMP +₹140 (22.15%)
📈 Qualiance Intl: GMP +₹55 (43.31%)

Amtech Esters Limited

 

 

Amtech Esters Limited: Initial Public Offering (IPO) & Fundamental Analysis Report

Executive Summary: Amtech Esters Limited is launching its Initial Public Offering (IPO) opening on September 09, 2026, and closing on September 11, 2026. The public issue is structured as a 100% Fresh Issue comprising up to 23,84,000 equity shares of face value ₹10 each. Operating out of Bahadurgarh, Haryana, Amtech Esters is a specialty chemical manufacturer focused on B2B production of Unsaturated Polyester Resins (UPRs), pigments, and allied industrial materials. Equity shares will be listed on the BSE SME platform.

1. IPO Structure & Key Capital Details

The public offering of Amtech Esters Limited is a book-built issue managed through Credora Partners Private Limited. The issue is purely a Fresh Equity Issue with no Offer for Sale (OFS) dilution by existing promoter shareholders. Below is the comprehensive timetable and structural breakdown of the IPO:

Fresh Issue Size
23,84,000 Shares
Face Value
₹10.00 / Share
FY26 Revenues
₹40.75 Crores
FY26 Net Profit (PAT)
₹4.22 Crores
Event / Parameter Details & Timelines
IPO Opening Date Wednesday, September 09, 2026
IPO Closing Date Friday, September 11, 2026
Basis of Allotment Finalization Tuesday, September 15, 2026
Initiation of Refunds / Unblocking Wednesday, September 16, 2026
Credit of Shares to Demat Accounts Wednesday, September 16, 2026
Tentative Listing Date Thursday, September 17, 2026
Face Value ₹10.00 per Equity Share
Total Pre-Issue Share Capital 64,45,168 Equity Shares
Total Post-Issue Share Capital 88,29,168 Equity Shares
Market Maker Reservation 1,20,000 Equity Shares (Nikunj Stock Brokers Ltd.)
Net Issue Reservation Breakdown QIB: 50.00% | NII/HNI: 15.00% | Retail: 35.00%
Book Running Lead Manager (BRLM) Credora Partners Private Limited
Registrar to the Offer Maashitla Securities Private Limited
Proposed Listing Exchange BSE SME

2. Corporate Profile & Operational Overview

Incorporated in May 2002 and converted into a public limited enterprise in December 2023, Amtech Esters Limited operates within the specialized chemical manufacturing domain. Headquartered in Karol Bagh, New Delhi, the company manages its primary manufacturing operations across two industrial facilities located in Bahadurgarh, Jhajjar district, Haryana, with an installed capacity exceeding 3,342 metric tonnes per annum (MTPA).

Core Product Offerings & Value Chain:

  • Unsaturated Polyester Resins (UPRs): B2B manufacturing of over 49 specialized SKUs of UPRs designed for structural composite applications, surface coatings, and casting resins.
  • Subsidiary Integration (Croda Pigments Pvt Ltd): Manufactures high-grade color pigments through its wholly owned subsidiary, CPPL, enhancing backward integration and composite resin formulations.
  • Trading of Complementary Products: Distributes fiberglass mats/strands, organic peroxide hardeners, silicone additives, and ancillary raw materials to provide end-to-end composite manufacturing solutions.
  • Diverse Industrial Applications: Products cater to sectors including automotive body panels, marine boats, electrical insulation, civil construction, paints & industrial coatings, fiber-reinforced plastics (FRP), and artificial marble furniture.
  • Quality Certifications & R&D: Maintains ISO 9001:2015 certified quality systems along with an in-house Research & Development facility for batch testing and custom customer formulations.

3. Comprehensive Financial Performance & Fundamental Metrics

Amtech Esters Limited has demonstrated steady financial expansion across key performance metrics between Financial Years 2024 and 2026. Higher capacity utilization and expanding product SKUs have driven both revenue growth and profit margin improvements.

Financial Metric (₹ in Crores) FY 2023-24 (FY24) FY 2024-25 (FY25) FY 2025-26 (FY26)
Total Revenue / Income ₹27.24 Cr ₹36.97 Cr ₹40.75 Cr
EBITDA ₹1.65 Cr ₹6.50 Cr ₹7.49 Cr
EBITDA Margin (%) 6.06% 17.58% 18.38%
Profit After Tax (PAT) ₹2.84 Cr ₹3.72 Cr ₹4.22 Cr
PAT Margin (%) 10.42% 10.06% 10.35%
Return on Equity (ROE / RoNW %) 24.40% 27.58% 24.17%
Return on Capital Employed (ROCE %) 18.10% 35.10% 30.16%
Debt-to-Equity Ratio 0.38x 0.26x 0.17x
Basic Earnings Per Share (EPS in ₹) ₹4.41 ₹5.78 ₹6.55
Net Asset Value (NAV per Share in ₹) ₹18.06 ₹23.83 ₹30.38
Financial Key Takeaway: Revenues expanded by 49.6% over two years from ₹27.24 Crores in FY24 to ₹40.75 Crores in FY26. Concurrently, PAT increased from ₹2.84 Crores to ₹4.22 Crores. The balance sheet shows strengthening fundamentals with the Debt-to-Equity ratio reducing from 0.38x to a low 0.17x in FY26, accompanied by a Return on Equity (ROE) of 24.17%.

4. Objects of the Fresh Issue & Capital Deployment Plan

The company plans to deploy the capital raised from the fresh issuance toward debt reduction and strategic expansion of its operating subsidiary:

  • Investment in Subsidiary (Croda Pigments Pvt Ltd): Allocating ₹8.81 Crores via inter-corporate debt/equity to fund capital expenditure for plant machinery expansion and meet incremental working capital demands.
  • Repayment / Prepayment of Borrowings: Utilizing ₹4.20 Crores to reduce outstanding short-term and long-term credit facilities, lowering annual interest expenses.
  • Inorganic Expansion & General Corporate Purposes: Funding potential acquisition opportunities, regulatory compliance expenses, brand building, and administrative costs.

5. Fundamental Evaluation: Key Strengths vs. Risk Analysis

Key Investment Strengths:

  • Integrated Chemical Business Model: Synergistic alignment between core UPR production, subsidiary pigment manufacturing, and trading of fiberglass/hardeners provides a single-window solution to industrial B2B clients.
  • Healthy Return Ratios: Consistent track record of delivering ROE above 24% and ROCE above 30%, reflecting capital efficiency in specialty chemical operations.
  • Low Financial Leverage: Conservative debt profile with a Debt-to-Equity ratio of 0.17x allows for interest cost savings and headroom for future operational expansion.
  • Experienced Management & Long Operating Track Record: Led by founders Ajit Singh Bawa and Gurpreet Kaur Bawa, backed by over two decades of experience in chemical manufacturing.

Potential Business & Market Risks:

  • Raw Material Price Volatility: Petrochemical derivative feedstocks used in UPR production are sensitive to global crude oil price fluctuations, which can impact operating margins.
  • Geographic Concentration: Both manufacturing plants are located in Bahadurgarh, Haryana, making operations susceptible to regional supply chain disruptions.
  • Working Capital Intensity: B2B chemical distribution requires maintaining high inventory levels and managing trade receivable credit terms.
  • SME Platform Liquidity: Listing on the BSE SME platform involves fixed trading lots, which can limit immediate secondary market trading liquidity compared to mainboard listings.

 

⚖️ Statutory Regulatory & Copyright Disclaimer

SEBI Compliance Note: ipoind.com is an independent financial analytics and primary market research portal provided solely for educational and informational purposes. We are NOT a SEBI-registered Investment Advisor or Research Analyst. Financial market investments, equity securities, and Initial Public Offerings (IPOs) carry inherent market risks.

Grey Market Premium (GMP) Notice: Figures regarding Grey Market Premium (GMP), Kostak rates, and subject-to-sauda deals reflect unofficial, unregulated over-the-counter market sentiment. These figures do not guarantee exchange listing prices or actual trading outcomes. Always evaluate official Draft Red Herring Prospectus (DRHP / RHP) documents filed with BSE/NSE and consult a certified financial advisor prior to executing financial bidding decisions.

© 2026 ipoind.com. All verified market intelligence, algorithmic layout structures, and curated analytics are protected.
Scroll to Top
⚡ IPOIND Directory
🔥 Live Tracking & Dashboards
⚡ Live GMP Today 📈 Live GMP & Sub Dashboard 📊 Day-Wise Subscription 📅 Upcoming IPO Pipeline
📋 Allotment, Quotas & Stories
🔍 Live Allotment Status 👥 Shareholder Quota Guide 📜 My 20 Allotments Record 📝 IPO Applying Strategy Guide
🧮 Interactive Financial Tools
🎯 Allotment Probability Calculator 📈 SIP Return Calculator 💵 Listing Gain Calculator
📚 Knowledge & Compliance Hub
💡 What is an IPO? 📑 Mainboard IPO Rules (SEBI) ⚖️ SME vs Mainboard Comparison 📂 DRHP Documents Hub 🏢 Unlisted Shares Hub
ℹ️ Company & Support
👤 About Our Platform 📩 Contact Support Desk
🤖
IPO Intelligence Brain v3.0
● Online • 50+ Financial Topics Synced
नमस्ते! मैं IPOIND Intelligence AI हूँ। 📈
मुझसे लाइव GMP, अलॉटमेंट प्रोबेबिलिटी, SEBI नियम, पैरेंट शेयरहोल्डर कोटा, या 20 वेरीफाइड IPOs (Bajaj Housing, Rajputana SME, Milky Mist, आदि) के केस स्टडी के बारे में कुछ भी विस्तार से पूछें!